Dr. Rod Rohrich Provides Medical Expertise on Kybella

May 04, 2015, 13:20 ET from Rod J. Rohrich, M.D., F.A.C.S

DALLAS, May 4, 2015 /PRNewswire/ -- The New York Times sought out medical insight over new injection, Kybella, from internationally acclaimed plastic surgeon, Dr. Rod Rohrich. Kybella, recently approved by the Food and Drug Administration, is proven to reduce fat deposits under the chin.

Photo - http://photos.prnewswire.com/prnh/20150504/213559

The active ingredient in Kybella, deoxycholic acid, dissolves the fat under the chin and gives plastic surgeons the ability to reshape this area without surgery. "So many consumers don't want a knife, they want a needle," said Dr. Rod Rohrich. Dr. Rohrich is frequently sought after for commentary on breakthrough industry practices and has made appearances on CNN, Oprah, The View, The Today Show, Wall Street Journal, The Dallas Morning News and has recently been featured in The New York Times and Inquisitr.

"For highly selected patients who have under-chin fat without sagging skin, this [Kybella injection] will work," said Dr. Rohrich.

Dr. Rod J. Rohrich, editor in chief of the journal of Plastic and Reconstructive Surgery and professor of plastic surgery at the University of Texas Southwestern Medical Center in Dallas, anticipated that both men and women will be intrigued by this procedure. From professional experience, Dr. Rohrich commented that men will be more interested to undergo a minimally invasive treatment at a doctor's office, than a surgical procedure.

However, multiple experts including Dr. Rohrich warned that not everyone is a good candidate for this treatment. Patients with excess fat and loose skin before undergoing the treatment will "need a neck lift after fat is reduced with the shot," according to Dr. Rohrich.

The F.D.A. issued a warning about injecting Kybella under the skin. Dr. Rohrich concurred, stating that "If you inject Kybella into the skin, you can hurt it" further noting that "this drug needs to go into fat tissue to work." Since this treatment is not yet commercially available, Dr. Rohrich emphasizes the importance of selecting a physician who is experienced with injectable treatments.

About Rod J. Rohrich, M.D., F.A.C.S

Dr. Rod J. Rohrich was the founding chair of the Department of plastic surgery at UTSW in Dallas and was the initial holder of the Betty and Warren Woodward Chair in Plastic and Reconstructive Surgery at UT Southwestern Medical Center as well as the Crystal Charity Ball Distinguished Chair in Plastic Surgery.

Dr. Rohrich graduated from Baylor College of Medicine with high honors, and completed residencies at the University of Michigan Medical Center and fellowships at Massachusetts General Hospital/Harvard (hand/microsurgery) and Oxford University (pediatric plastic surgery). Dr. Rohrich has served as president of the American Society of Plastic Surgeons, the largest organization of board certified plastic surgeons in the world. He has repeatedly been selected by his peers as one of America's best doctors, and twice has received one of his profession's highest honors, the Plastic Surgery Educational Foundation Distinguished Service Award, which recognizes his contributions to education in plastic surgery.

Dr. Rohrich participates in and has led numerous associations and councils for the advancement of plastic and reconstructive surgery. He is a native of North Dakota and is married to Dr. Diane Gibby, also a plastic surgeon. They live in Dallas with their two children.

You can follow Dr. Rod J. Rohrich's recent endeavors through Facebook, Twitter and LinkedIn.


SOURCE Rod J. Rohrich, M.D., F.A.C.S